Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
Nephrol Dial Transplant. 2020 Nov 1;35(11):1984-1995. doi: 10.1093/ndt/gfaa151.
Replicative senescence is associated with telomere shortening. In native kidneys, obtained prior to transplantation, we recently described and validated a significant association between shorter intrarenal telomere length and renal arteriosclerosis. After renal transplantation, animal experiments suggested that ischaemia-reperfusion injury, acute rejection episodes and cytomegalovirus disease associate with accelerated renal allograft senescence. The association between post-transplant events and replicative senescence has not yet been evaluated in a human setting.
In a cohort of 134 kidney allograft recipients, we performed protocol-specified renal allograft biopsies at 3 months, 1 year, 2 years and 5 years after transplantation (n = 579 biopsies). We used quantitative real-time polymerase chain reaction to measure intrarenal relative average telomere length (T/S ratio). The association between donor and recipient demographic factors, post-transplant clinical/histological events, renal allograft histological evolution by 5 years post-transplant and intrarenal telomere length at 5 years after transplantation was studied using multiple regression models.
At 5 years after transplantation, shorter intrarenal telomere length was associated with male donor gender, older donor age, donor history of hypertension and donor cardiovascular risk, which confirms the associations observed in native kidneys. Recipient characteristics and post-transplant events like delayed graft function, acute rejection episodes, presence of donor-specific antibodies, cytomegalovirus disease and immunosuppressive regimen did not associate with alterations of intrarenal telomere length at 5 years. Independent of donor age and donor cardiovascular risk, intrarenal arteriosclerosis in protocol biopsies obtained at 5 years after transplantation and progressive arteriosclerosis over time after transplantation associated with shorter telomere length, while this was not the case for other histological lesions. Moreover, telomere attrition augments the association between older donor age and the presence of severe arteriosclerosis. In the group with the oldest donor age and shortest telomere length, there was significantly more severe arteriosclerosis (43%) in protocol biopsies at 5 years after transplantation, compared with other combinations (13-28%) (P = 0.001). Intrarenal arteriosclerosis at 5 years after transplantation did not associate with post-transplant clinical events.
We demonstrate that intrarenal telomere length at 5 years after transplantation, as a marker for replicative senescence, associates with renal arteriosclerosis and reflects kidney donor characteristics, but not post-transplant events.
复制性衰老与端粒缩短有关。在我们最近描述和验证的供体肾脏中,获得移植前的原发性肾脏中,发现肾内端粒长度较短与肾小动脉粥样硬化有显著相关性。肾移植后,动物实验表明,缺血再灌注损伤、急性排斥反应和巨细胞病毒病与加速肾移植衰老有关。然而,在人类环境中,尚未评估移植后事件与复制性衰老之间的关联。
在 134 名肾移植受者的队列中,我们在移植后 3 个月、1 年、2 年和 5 年进行了规定的肾移植活检(n = 579 次活检)。我们使用实时定量聚合酶链反应测量肾内相对平均端粒长度(T/S 比值)。使用多元回归模型研究了供者和受者人口统计学因素、移植后临床/组织学事件、移植后 5 年内肾移植组织学演变以及移植后 5 年内肾内端粒长度之间的关系。
在移植后 5 年时,较短的肾内端粒长度与供者的男性性别、年龄较大、供者高血压和心血管风险史相关,这证实了在供体肾脏中观察到的相关性。受者特征和移植后事件,如延迟移植物功能、急性排斥反应、供者特异性抗体存在、巨细胞病毒病和免疫抑制方案,与 5 年后肾内端粒长度的改变无关。独立于供者年龄和供者心血管风险,在移植后 5 年获得的方案活检中肾内动脉粥样硬化以及移植后随时间进展的进行性动脉粥样硬化与端粒缩短相关,而其他组织学病变则不然。此外,端粒损耗加剧了供者年龄较大和严重动脉粥样硬化存在之间的关联。在供者年龄最大且端粒最短的组中,与其他组合(13%-28%)相比,在移植后 5 年的方案活检中严重动脉粥样硬化的比例显著更高(43%)(P = 0.001)。移植后 5 年时肾内动脉粥样硬化与移植后临床事件无关。
我们证明,移植后 5 年时肾内端粒长度作为复制性衰老的标志物,与肾小动脉粥样硬化相关,并反映肾脏供者特征,但与移植后事件无关。